Zenith Drugs Ltd
NSE: ZENITHDRUG BSE: 92356
₹39.95
(3.90%)
Wed, 08 Apr 2026, 09:10 am
Market Cap653.37M
PE Ratio18.14
Dividend1.31
Health Technology
Pharmaceuticals: Major
24.5KZenith Drugs Financials
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total revenue | 734.02M | 916.55M | 1.15B | 1.32B | 1.33B |
| Gross profit | 173.04M | 146.07M | 236.35M | 311.59M | 257.00M |
| Operating expenses (excl. COGS) | -105.16M | -80.50M | -132.24M | -138.49M | -129.35M |
| Selling/general/admin expenses, total | -102.00M | -78.78M | -121.72M | -129.28M | -125.61M |
| Research & development | — | — | — | — | — |
| Selling/general/admin expenses, other | -102.00M | -78.78M | -121.72M | -129.28M | -125.61M |
| Other operating expenses, total | -3.16M | -1.72M | -10.53M | -9.21M | -3.73M |
| Operating income | 67.88M | 65.58M | 104.11M | 173.10M | 127.65M |
| Non-operating income, total | -21.86M | -21.52M | -32.00M | -40.18M | -35.04M |
| Interest expense, net of interest capitalized | -13.24M | -21.10M | -23.36M | -29.97M | -37.11M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.14M | 9.44M | 11.77M | 21.20M | 26.03M |
| Non-operating interest income | 612.00K | 5.22M | 1.60M | 10.83M | 19.01M |
| Miscellaneous non-operating expense | 523.00K | 4.22M | 10.17M | 10.37M | 7.02M |
| Unusual income/expense | -9.75M | -9.86M | -20.42M | -31.41M | -23.96M |
| Pretax income | 46.02M | 44.06M | 72.10M | 132.92M | 92.61M |
| Taxes | -15.73M | -12.77M | -20.57M | -37.55M | -21.00M |
| Non-controlling/minority interest | 0 | 96.00K | 4.00K | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 30.29M | 31.38M | 51.53M | 95.37M | 71.61M |
| Net income | 30.29M | 31.38M | 51.53M | 95.37M | 71.61M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 30.29M | 31.38M | 51.53M | 95.37M | 71.61M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - |
| EBITDA | 80.04M | 78.84M | 117.13M | 186.13M | 157.31M |
| EBIT | 67.88M | 65.58M | 104.11M | 173.10M | 127.65M |
| Total operating expenses | -666.14M | -850.97M | -1.04B | -1.14B | -1.21B |
| Prepaid expenses | 205.00K | 3.37M | 3.12M | — | — |
| Deferred income, current | — | — | — | — | — |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — |
| Deferred tax liabilities | 3.08M | 2.63M | 4.19M | — | — |
| Deferred income, non-current | — | — | — | — | — |
| Minority interest | 0 | 149.00K | 145.00K | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800